2019
DOI: 10.3390/cancers11060829
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging

Abstract: Radiographic assessment with magnetic resonance imaging (MRI) is widely used to characterize gliomas, which represent 80% of all primary malignant brain tumors. Unfortunately, glioma biology is marked by heterogeneous angiogenesis, cellular proliferation, cellular invasion, and apoptosis. This translates into varying degrees of enhancement, edema, and necrosis, making reliable imaging assessment challenging. Deep learning, a subset of machine learning artificial intelligence, has gained traction as a method, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
66
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 84 publications
(79 citation statements)
references
References 69 publications
(87 reference statements)
0
66
0
1
Order By: Relevance
“…Fast and reliable labeling (contouring) of these segments is a crucial task in many areas of neuro-oncology such as radiotherapy and image-based follow-up [ 44 ]. Numerous algorithms have been developed for this purpose [ 45 ] and a periodically held challenge (the Multimodal Brain Tumor Image Segmentation Benchmark, BRATS) has been set up to compare their efficacy [ 41 , 46 ]. Today, the best-performing tools are usually based on CNNs [ 47 , 48 ], which achieve high segmentation accuracies (Dice similarity coefficients) where almost 90% of the voxels are correctly labeled, which is the order of magnitude that experienced physicians can achieve [ 44 ].…”
Section: Gliomamentioning
confidence: 99%
“…Fast and reliable labeling (contouring) of these segments is a crucial task in many areas of neuro-oncology such as radiotherapy and image-based follow-up [ 44 ]. Numerous algorithms have been developed for this purpose [ 45 ] and a periodically held challenge (the Multimodal Brain Tumor Image Segmentation Benchmark, BRATS) has been set up to compare their efficacy [ 41 , 46 ]. Today, the best-performing tools are usually based on CNNs [ 47 , 48 ], which achieve high segmentation accuracies (Dice similarity coefficients) where almost 90% of the voxels are correctly labeled, which is the order of magnitude that experienced physicians can achieve [ 44 ].…”
Section: Gliomamentioning
confidence: 99%
“…[14] Machine [15] Human brain study using AI 6317 bibliometric analysis from 19 to 350). Besides, the existing reviews focus on narrowed and particular topics, for example, deep learning approaches for glioma imaging [7], machine learning in acute ischemic stroke [8], and AI in stroke imaging [6], failing to provide a general overview of the community of AI-enhanced human brain research. In addition, these qualitative reviews on specific topics or bibliometric analyses based primarily on metadata of scientific publications (e.g., year of publication or citation index) cannot accommodate the wide and fast-growing research and application scopes of modern AI-assisted human brain research.…”
Section: -2019mentioning
confidence: 99%
“…Artificial intelligence (AI) is a promising tool to improve prostate lesion detection, lesion characterization, and lesion volume quantification. AI can systematically evaluate mpMRI images [38]. Machine learning (ML), a branch of AI, and its sub-discipline, deep learning (DL), have become attractive techniques in medical imaging because of their ability to interpret large amounts of data [39].…”
Section: Introductionmentioning
confidence: 99%